132 related articles for article (PubMed ID: 11801324)
1. Cdk5 sinks into ALS.
Patzke H; Tsai LH
Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.
Nguyen MD; Boudreau M; Kriz J; Couillard-Després S; Kaplan DR; Julien JP
J Neurosci; 2003 Mar; 23(6):2131-40. PubMed ID: 12657672
[TBL] [Abstract][Full Text] [Related]
3. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25.
Takahashi S; Kulkarni AB
J Neurochem; 2004 Mar; 88(5):1295-304. PubMed ID: 15009685
[TBL] [Abstract][Full Text] [Related]
4. Fas(t) balls and Lou Gehrig disease. A clue to selective vulnerability of motor neurons?
Xiong ZQ; McNamara JO
Neuron; 2002 Sep; 35(6):1011-3. PubMed ID: 12354390
[TBL] [Abstract][Full Text] [Related]
5. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
Nguyen MD; Larivière RC; Julien JP
Neuron; 2001 Apr; 30(1):135-47. PubMed ID: 11343650
[TBL] [Abstract][Full Text] [Related]
7. Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T; Rothstein JD
Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
Pasinelli P; Brown RH
Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
[TBL] [Abstract][Full Text] [Related]
9. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
Bacman SR; Bradley WG; Moraes CT
Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment.
Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S
Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328
[TBL] [Abstract][Full Text] [Related]
12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis.
Bajaj NP
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1(5):319-27. PubMed ID: 11464850
[TBL] [Abstract][Full Text] [Related]
14. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.
Bk B; Skuntz S; Prochazkova M; Kesavapany S; Amin ND; Shukla V; Grant P; Kulkarni AB; Pant HC
Hum Mol Genet; 2019 Oct; 28(19):3175-3187. PubMed ID: 31189016
[TBL] [Abstract][Full Text] [Related]
16. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
17. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
18. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
